Antimicrobial drug pricing

Despite the constant development of antimicrobial resistance (AMR), few new antimicrobials are currently becoming available clinically. Alternative approaches, such as different mechanisms to fund their use, are being explored to encourage development of new antimicrobials.

Saved in:
Bibliographic Details
Main Authors: Avaneesh Kumar Pandey, Nusrat Shafiq, Ashish Kumar Kakkar, Samir Malhotra, Beth Woods, Christopher Little, Tom Rhodes, Harriet Tuson, Zeshan Riaz, Tom Ashfield, Michael Corley, Ioannis Baltas
Format: Article
Language:English
Published: Nature Portfolio 2024-10-01
Series:Communications Medicine
Online Access:https://doi.org/10.1038/s43856-024-00594-9
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Despite the constant development of antimicrobial resistance (AMR), few new antimicrobials are currently becoming available clinically. Alternative approaches, such as different mechanisms to fund their use, are being explored to encourage development of new antimicrobials.
ISSN:2730-664X